SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0000950170-23-014588 from Aveanna Healthcare Holdings, Inc. (AVAH) (CIK 0001832332) (AVAH)

Aveanna Healthcare Holdings, Inc. (AVAH) (CIK 0001832332)
Date: April 26, 2023 · CIK: 0001832332 · Accession: 0000950170-23-014588

AI Filing Summary & Sentiment

File numbers found in text: 001-40362

Referenced dates: April 20, 2023

Date
April 26, 2023
Author
By
Form
CORRESP
Company
Aveanna Healthcare Holdings, Inc. (AVAH) (CIK 0001832332)

Letter

Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561

Re: Aveanna Healthcare Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 16, 2023 File No. 001-40362

Dear Ms. Wong and Mr. Cascio:

On behalf of Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”), set forth below is the Company’s response to the comment of the Staff communicated to the Company in the Staff’s letter, dated April 20, 2023, with respect to the Company’s Form 10-K for the Fiscal Year Ended December 31, 2022 (the “Form 10-K”) filed with the Securities and Exchange Commission on March 16, 2023.

For ease of reference, the Staff’s comment is reproduced below in bold and is followed by the Company’s response.

Form 10-K for the Fiscal Year Ended December 31, 2022

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Non-GAAP Financial Measures, page 67

1.In future filings, please revise to reconcile the non-GAAP measure “Field Contribution” and “Field Contribution Margin” to the most comparable GAAP measure, which appears to be gross margin, even if it is not presented on the face of the Consolidated Statement of Operations. Please also revise the similar reconciliation in Exhibit 99.1 to your Form 8-K.

In response to the Staff’s comment, the Company will reconcile the non-GAAP measure Field Contribution and Field Contribution Margin to Gross Margin in its future filings, as well as in each earnings release furnished as Exhibit 99.1 to a Current Report on Form 8-K.

If you have any questions or comments concerning this response or require any additional information, please do not hesitate to call the undersigned at (770) 441-1580.

Sincerely,
Aveanna Healthcare Holdings Inc.

Show Raw Text
CORRESP
1
filename1.htm

  CORRESP

  April 26, 2023

  Ms. Christie Wong and Mr. Brian Cascio
Office of Industrial Applications and Services

  Securities and Exchange Commission

  Division of Corporation Finance

  100 F Street NE

  Washington, D.C. 20549-3561

  Re:      Aveanna Healthcare Holdings, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed March 16, 2023
File No. 001-40362

  Dear Ms. Wong and Mr. Cascio:

  On behalf of Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”), set forth below is the Company’s response to the comment of the Staff communicated to the Company in the Staff’s letter, dated April 20, 2023, with respect to the Company’s Form 10-K for the Fiscal Year Ended December 31, 2022 (the “Form 10-K”) filed with the Securities and Exchange Commission on March 16, 2023.

  For ease of reference, the Staff’s comment is reproduced below in bold and is followed by the Company’s response.

  Form 10-K for the Fiscal Year Ended December 31, 2022

  Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

  Non-GAAP Financial Measures, page 67

  1.In future filings, please revise to reconcile the non-GAAP measure “Field Contribution” and “Field Contribution Margin” to the most comparable GAAP measure, which appears to be gross margin, even if it is not presented on the face of the Consolidated Statement of Operations. Please also revise the similar reconciliation in Exhibit 99.1 to your Form 8-K.

  In response to the Staff’s comment, the Company will reconcile the non-GAAP measure Field Contribution and Field Contribution Margin to Gross Margin in its future filings, as well as in each earnings release furnished as Exhibit 99.1 to a Current Report on Form 8-K.

  If you have any questions or comments concerning this response or require any additional information, please do not hesitate to call the undersigned at (770) 441-1580.

   Sincerely,

   Aveanna Healthcare Holdings Inc.

      By:

    /s/ David Afshar

    David Afshar

    Chief Financial Officer